ISO/TR 11147:2023
2023-06
ISO/TR 11147:2023
Тезис
This document lists characteristics of a category of health software: digital therapeutics (DTx). DTx products generate and deliver medical interventions that are based on clinical evidence, have demonstrable positive therapeutic impacts on patient health, and produce real-world outcomes. Product use cases (see Annex B) demonstrate the variety of products represented in this quickly growing industry.
This document provides an overview of how DTx relates to other ecosystem constructs, including medical devices, software as a medical device (SaMD), software in a medical device (SiMD), and other digital health technologies (DHT). It also addresses relevant health and medical device software standards that have various degrees of applicability to DTx.
The focus of this document is on therapeutic products that are used in the context of a disease, disorder, condition, or injury for human use. It does not address products that are intended for veterinary use or for general wellbeing. Additional exclusions of this document include DTx market access pathways (i.e. prescription, non-prescription pathways), medical device requirements, product risk assessment, clinical evidence requirements, data security, patient privacy considerations, and product authorization pathways.
Общая информация
-
Текущий статус: ОпубликованоДата публикации: 2023-06Этап: Опубликование международного стандарта [60.60]
-
Версия: 1
-
Технический комитет :ISO/TC 215ICS :35.240.80
- RSS обновления
Жизненный цикл
-
Сейчас
-
00
Предварительная стадия
-
10
Стадия, связанная с внесением предложения
-
20
Подготовительная стадия
-
30
Стадия, связанная с подготовкой проекта комитета
-
40
Стадия, связанная с рассмотрением проекта международного стандарта
-
50
Стадия, на которой осуществляется принятие стандарта
-
60
Стадия, на которой осуществляется публикация
-
90
Стадия пересмотра
-
95
Стадия, на которой осуществляется отмена стандарта
-
00